# ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/abt-199-venetoclax-and-bcl-2-inhibitors-in-clinical-development/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Shundong Cang,Chaitanya Iragavarapu,John Savooji,Yongping Song,Delong Liu |
| Citations | 284 |
| DOI | 10.1186/s13045-015-0224-3 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://jhoonline.biomedcentral.com/track/pdf/10.1186/s13045-015-0224-3 |
| OpenAlex ID | https://openalex.org/W2178124407 |
| PMID | 26589495 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Shundong Cang](https://scholariq.org/researchers/shundong-cang/)

## Paper primary topic

- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)

## Paper topics

- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.